{"@type": "dcat:Dataset", "accessLevel": "public", "bureauCode": ["009:25"], "contactPoint": {"@type": "vcard:Contact", "fn": "NIH/NCBI Data Team", "hasEmail": "mailto:info@ncbi.nlm.nih.gov"}, "description": "Cosmetic or dermatological formulations which comprise one or more active ingredients selected from phylloquinone, 2-hydroxy-5-methyllaurophenone oxime, vitamin A and its derivatives, vitamin E and its derivatives, vitamin H, allantoin, bisabolol, nicotinic acid derivatives and caffeine and in addition (a) one or more antioxidants and/or (b) one or more UV filters, are distinguished, in particular, by the fact that the active ingredients present in the formulation according to the invention are stabilised.", "distribution": [{"@type": "dcat:Distribution", "description": "Access the complete Patent AT-E399529-T1: [Translated] GALENIC FORMULATION on the official website.", "downloadURL": "https://pubchem.ncbi.nlm.nih.gov/patent/AT-E399529-T1", "mediaType": "text/html", "title": "Official Data Source"}], "identifier": "https://healthdata.gov/api/views/r5rw-3zre", "issued": "2025-09-05", "keyword": ["chemistry", "innovation", "patent", "pubchem", "research"], "landingPage": "https://healthdata.gov/d/r5rw-3zre", "modified": "2025-09-06", "programCode": ["009:066"], "publisher": {"@type": "org:Organization", "name": "National Center for Biotechnology Information (NCBI)"}, "theme": ["NIH"], "title": "Patent AT-E399529-T1: [Translated] GALENIC FORMULATION"}